Post by
Gbathat on Dec 09, 2020 10:10am
PMN has quality science
For those who question the level of science from PMN, and who are not convinced by the featured presentations by Dr. Cashman at the leading symposia in this field, I'd like to point out the that PMN310 paper was published in one of the most rigorously peer reviewed journals in the world.
https://www.nature.com/srep/about
Scientific Reports is the 7th most-cited journal in the world, with more than 350,000 citations in 2019*, and receives widespread attention in policy documents and the media.
Here is a link to the article
https://pubmed.ncbi.nlm.nih.gov/31285517/
Comment by
Actuarial on Dec 09, 2020 10:27am
No one question the science, we just question if the management team ever be able to bring PMN through clinical ...... with no cash, no plan ......
Comment by
farmerjane on Dec 09, 2020 1:05pm
Pharma finds quality science, but after a few years of pharma discussions what's really going on? They have a plan but is it in all shareholders interest?